Skip to main content
OpenTrials
Completed

NCT Number: NCT02890251

Visual Maturation in Premature Newborns According to Factors Influencing Its Development

The purpose is to describe the level of visual maturation of premature newborns at term equivalent age.

The secondary purpose is to determine factors associated to an altered level of visual maturation, through an exploratory approach.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Infants born before 33 weeks of amenorrhea and hospitalized at CHRU Nancy

Exclusion criteria

  • Parental opposition
  • Ocular malformation
  • Face malformation
  • Cranial stenosis
  • Chromosomal abnormality

Treatment and study plan

Primary outcomes

  1. Measurement of Visual Acuity by Baby Vision Cards

    Time frame: Baseline

    Baby Vision cards are the French equivalent of Teller Cards - The measurement will be done at the term equivalent age : at the inclusion

Secondary outcomes

  1. Control of the Retina by Retinal Camera

    Time frame: Baseline

    Use of Retcam to diagnose Retinopathy of Prematurity - The measurement will be done at the term equivalent age : at the inclusion

  2. Measurement of cycloplegic refraction by mydriaticum 0.5%

    Time frame: Baseline

    The measurement will be done at the term equivalent age : at the inclusion

  3. Presence, absence of light reflex by clinical evaluation

    Time frame: Baseline

    The measurement will be done at the term equivalent age : at the inclusion

  4. Presence, absence or abnormality of visual fixation by clinical observation

    Time frame: Baseline

    The measurement will be done at the term equivalent age : at the inclusion

  5. Analysis of visual cortex with MRI

    Time frame: Baseline

    Determinants of indices of cerebral volume in former very premature infants and their relation to visual maturation. The measurement will be done at the term equivalent age : at the inclusion

Sponsors and collaborators

Lead sponsor

Central Hospital, Nancy, France

Other

Registry information

Acronym: PREMAVISION

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Sep 7, 2016
Registry last updated
Feb 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.